<DOC>
	<DOCNO>NCT03102138</DOCNO>
	<brief_summary>This safety follow-up study . Patients enrol B4711001 follow 4 year regular visit assess safety .</brief_summary>
	<brief_title>Retinal Pigment Epithelium Safety Study For Patients In B4711001</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<criteria>Evidence personally sign date informed consent document indicate subject inform pertinent aspect study . Previous participation Protocol B4711001 receive treatment PF05206388 . Subjects willing able comply schedule visit , study procedure . exclusion criterion</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>